Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$259,145,283
+$153,482,260 QoQ
Shares Held
33,012,138
+9.0% QoQ
Ownership
10.8%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#1
of 150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAKER BROS. ADVISORS LP holds $18,876,485,415 across 78 Biotechnology names. ABCL ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,762,330 | $3,487,217,728 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,801,567 | $2,508,182,547 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
11,443,357 | $2,143,111,898 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,143,131 | $1,150,754,190 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,912,904 | $1,085,696,471 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
8,657,242 | $992,725,940 | |
| 7 | INSM |
INSMED Inc
|
8,796,111 | $937,841,354 | |
| 8 | CELC |
Celcuity Inc.
|
7,915,792 | $828,150,159 |
All Filings in ABCL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $259,145,283 | 33,012,138 | Shares | Sole | 2026-08-14 | |
| 2026-04-30 | $136,010,008 | 33,012,138 | Shares | Sole | 2026-05-07 | |
| 2026-03-31 | $105,663,023 | 30,275,938 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $94,137,688 | 27,525,640 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $138,453,969 | 27,525,640 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $94,412,945 | 27,525,640 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,382,177 | 27,525,640 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $80,650,125 | 27,525,640 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $71,566,664 | 27,525,640 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $81,475,894 | 27,525,640 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $124,691,149 | 27,525,640 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $130,814,689 | 22,909,753 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $95,511,285 | 20,763,323 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $106,268,162 | 16,450,180 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $78,794,357 | 10,450,180 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $105,860,323 | 10,450,180 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $103,352,280 | 10,450,180 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $111,294,417 | 10,450,180 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $101,889,255 | 10,450,180 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $149,437,574 | 10,450,180 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $209,421,607 | 10,450,180 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $229,903,960 | 10,450,180 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $354,888,112 | 10,450,180 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $420,515,243 | 10,450,180 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||